Purna Chandra Ray, Yogesh Dadaji Pawar, Dnyaneshwar Tukaram Singare, Tushar Nandkumar Deshpande, Girij Pal Singh
Index: 10.1021/acs.oprd.8b00011
Full Text: HTML
A novel process for the synthesis of tetrabenazine (1) and deutetrabenazine (2), two well-known drugs used for the treatment of chorea associated with Huntington’s disease, has been developed. All of the reaction parameters were optimized through a series of reactions and by using Design of Experiment techniques. The newly developed methods are industrially scalable and employ cheap, commercially available raw materials and hence are highly efficient. The added advantage is that the developed processes evade the use of genotoxic alkylating agents and therefore could be considered as safe and viable alternatives to the existing methods.
Palladium-Catalyzed C–O Coupling of a Sterically Hindered Se...
2018-04-12 [10.1021/acs.oprd.8b00022] |
UV PhotoVap: Demonstrating How a Simple and Versatile Reacto...
2018-04-12 [10.1021/acs.oprd.8b00037] |
Ir-Catalyzed Borylation as an Efficient Route to a Nicotine ...
2018-04-09 [10.1021/acs.oprd.8b00053] |
Crystallization of a Metastable Solvate and Impact of the Is...
2018-04-09 [10.1021/acs.oprd.8b00062] |
Synthetic Strategies toward SGLT2 Inhibitors
2018-04-09 [10.1021/acs.oprd.8b00017] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved